{"id":"W1969093054","doi":"10.1002/art.23715","title":"Improvement in patient‐reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy","year":2008,"lang":"en","type":"article","venue":"Arthritis Care & Research","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Versus Arthritis","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Internal medicine; Placebo; Rheumatology; Physical therapy; Refractory (planetary science); Methotrexate; Population; Quality of life (healthcare); Lymphoma; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003042175,0.000767095,0.002649123,0.0002697594,0.0003371271,0.0009100634,0.0005118874,0.001181844,0.001770751],"category_scores_gemma":[0.002653277,0.0003407255,0.001347514,0.0003207729,0.0005902976,0.0004638963,0.0003406506,0.001573647,0.0002664476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003525752,"about_ca_system_score_gemma":0.0004599864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002796084,"about_ca_topic_score_gemma":0.0006847724,"domain_scores_codex":[0.998189,0.00128558,0.0001432315,0.0001259256,0.000150832,0.0001052757],"domain_scores_gemma":[0.9982222,0.0006311373,0.0005286978,0.00008431411,0.00009056157,0.0004431413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9504352,0.004700651,0.005402594,0.001182858,0.003317917,0.0000693176,0.00008345319,0.0005543014,0.003654382,0.00006123433,0.0007667922,0.02977141],"study_design_scores_gemma":[0.8063568,0.1600665,0.0287799,0.0001185765,0.001903927,0.000161881,0.0000422171,0.0007603899,0.0005340797,0.00009446046,0.001154804,0.00002639426],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875816,0.01003672,0.0001521565,0.0004105302,0.0001573313,0.0004329371,0.0002225046,0.0000264992,0.0009798413],"genre_scores_gemma":[0.994894,0.002335434,0.0003835661,0.0005303806,0.0003481225,0.0007051508,0.000371158,0.000004582884,0.0004276058],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003042175,"threshold_uncertainty_score":0.01608878,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02804946037120711,"score_gpt":0.3068926925377501,"score_spread":0.2788432321665431,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}